PF-06463922 for Crizotinib Pretreated ROS1 Positive Non-small-cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung Intervention: Drug: PF-06463922 (Lorlatinb) Sponsors: Fondazione Ricerca Traslazionale; Clinical Research Technology S.r.l. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials